Forcing the phenyl moiety into the axial position by embedding the 2-pheny-1,3dioxane system in a tricyclic benzomorphan scaffold: Design, synthesis and biological evaluation

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to explore how specific structural arrangements affect interactions with sigma-1 and NMDA receptors.
Designed and synthesized a tricyclic benzomorphan scaffold containing the 2-pheny-1,3-dioxane system.
Conducted biological evaluations to assess receptor interactions.
Utilized qualitative analysis to understand the impact of relative configuration and substitution patterns.
Identified significant interactions of the synthesized compounds with sigma-1 receptors.
Demonstrated varying effects on the PCP binding site of NMDA receptors depending on the configuration.
Suggests optimization of scaffold design can enhance pharmacological activity.

Evaluating sigma-1 receptor interactions in a new benzomorphan compound, suggesting a novel drug design approach.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Schulte-Gauczinski et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share